CLINICAL TRIALS PROFILE FOR DIQUAFOSOL

Clinical Trials for Diquafosol

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00403715 ↗	Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease	Completed	Merck Sharp & Dohme Corp.	Phase 3	The purpose of this trial is to compare the effectiveness and safety of INS365 Ophthalmic Solution with Placebo when applied topically in subjects with dry eye disease.
NCT00403975 ↗	Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease	Completed	Merck Sharp & Dohme Corp.	Phase 3	The purpose of this trial is to assess the effectiveness and safety of 2% diquafosol tetrasodium ophthalmic solution versus placebo following 6 weeks of treatment in subjects with mild to moderate dry eye disease.
NCT00404131 ↗	Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease	Completed	Merck Sharp & Dohme Corp.	Phase 3	The purpose of this trial is to compare the effectiveness and safety of INS365 Ophthalmic Solution with placebo when applied topically in subjects with dry eye disease.

Clinical Trial Conditions for Diquafosol

Condition Name

Condition Name
Intervention	Trials
Dry Eye Disease	9
Dry Eye	5
Dry Eye Syndromes	4

Condition MeSH

Condition MeSH
Intervention	Trials
Keratoconjunctivitis Sicca	20
Dry Eye Syndromes	20
Eye Diseases	10

Clinical Trial Locations for Diquafosol

Trials by Country

Trials by Country
Location	Trials
China	7
Korea, Republic of	4
Singapore	1
Indonesia	1

Clinical Trial Progress for Diquafosol

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	6
Phase 2	4

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	13
Not yet recruiting	6
Recruiting	2

Clinical Trial Sponsors for Diquafosol

Sponsor Name

Sponsor Name
Sponsor	Trials
Merck Sharp & Dohme Corp.	8
He Eye Hospital	5
Santen Pharmaceutical Co., Ltd.	2

Sponsor Type

Sponsor Type
Sponsor	Trials
Industry	13
Other	11